Select language:  
1800 620 420
Close menu

COVID has been beneficial to some WM patients

“COVID’s been good to me and quite a few other patients”, says Andrew Warden, who volunteered to be a “guinea pig” on a program initiated by Professor Judith Trotman.

  • Non-Hodgkin lymphoma
Read more
Andrew Warden and Judith Trotman

Mogamulizumab being considered again by PBAC

A resubmission will be considered from Kyowa Kirin for relapsed or refractory (R/R) cutaneous T-cell lymphoma.

  • Non-Hodgkin lymphoma
Read more
Mogamulizumab illustration

John is positive his lymphoma is cured

It’s been 10 years since John Taylor’s last follow-up consultation with his haematologist.

  • Non-Hodgkin lymphoma
Read more
John-Taylor-lymphoma

New treatment now available through PBS for cutaneous T-cell lymphoma patients

  • Media releases
  • Research
Read more
Scientist in lab